Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $204.41. The company's market cap stands at 492.36B, with a P/E ratio of 19.86 and a dividend yield of 2.5%.
On 2026-01-09, Johnson & Johnson(JNJ) stock traded between a low of $204.01 and a high of $206.70. Shares are currently priced at $204.41, which is +0.2% above the low and -1.1% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 6.15M, against a daily average of 5.89M.
During the past year, Johnson & Johnson(JNJ) stock moved between $140.68 at its lowest and $215.19 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $140.68 at its lowest and $215.19 at its peak.
JNJ News
Bernstein analyst Lee Hambright raised the firm’s price target on Johnson & Johnson to $208 from $193 and keeps a Market Perform rating on the shares. After a l...
Biotech and Pharma Johnson & Johnson Strikes Deal With White House to Lower Drug Prices In this article JNJ NOVN MRK GSK Johnson & Johnson agrees to lower price...
↘️ General Motors (GM) : The carmaker said it would book a $6 billion charge on its money-losing electric-vehicle business. Shares dropped 1.4% in offhours trad...
Analyst ratings
56%
of 27 ratingsMore JNJ News
Johnson & Johnson (NYSE:JNJ) struck a deal with the Trump administration on Thursday to lower drug prices for U.S. consumers in exchange for exemptions from tar...
(RTTNews) - Drug major Johnson & Johnson has announced an agreement with the Trump Administration to lower drug prices, enabling millions of Americans to access...
Johnson & Johnson (JNJ) reached a significant agreement with the Trump administration to lower drug prices for Americans while securing exemptions from U.S. tar...
J&J’s agreement with the Trump administration follows similar drug-pricing deals between the administration and other pharmaceutical companies. Maxim Shemetov/R...
Johnson & Johnson said that, as part of its previously announced $55B investment to support U.S. manufacturing, it is announcing two new U.S. manufacturing faci...
Johnson & Johnson announced a voluntary agreement with the Trump Administration to “improve access to medicines and lower costs for millions of American patient...
Lexeo Therapeutics (LXEO) announced a research collaboration with Johnson & Johnson (JNJ) to investigate localized cardiac delivery of gene therapy. The collabo...